S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q2 2025

Perceptive Advisors

Period: Q2 2025 Β· Filed: 2025-08-14
View on SEC EDGAR β†—
AUM
$2.70B
Total portfolio value
Positions
85
Reported securities
Top Holding
VRNA
19.3% $520.9M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
VRNAVERONA PHARMA PLC$520.9M19.31%β€”β€”
19.3%
ASNDASCENDIS PHARMA A/S$166.4M6.17%$172.60$274.50+59.0%
6.2%
ACLXARCELLX INC$163.2M6.05%$65.85β€”
6.0%
RYTMRHYTHM PHARMACEUTICALS INC$152.8M5.67%$63.19$114.17+80.7%
5.7%
NUVLNUVALENT INC$104.9M3.89%$76.30$123.73+62.2%
3.9%
AORTARTIVION INC$86.9M3.22%$31.10$23.97-22.9%
3.2%
MGTXMEIRAGTX HLDGS PLC$82.2M3.05%$6.52$13.92+113.5%
3.0%
INSMINSMED INC$65.4M2.43%$100.64$111.60+10.9%
2.4%
EWTXEDGEWISE THERAPEUTICS INC$60.8M2.26%$13.11$39.56+201.8%
2.3%
PTGXPROTAGONIST THERAPEUTICS INC$59.4M2.20%$55.27$131.62+138.1%
2.2%
SLDBSOLID BIOSCIENCES INC$58.0M2.15%$4.87$10.84+122.6%
2.1%
APGEAPOGEE THERAPEUTICS INC$51.3M1.90%$43.43$132.91+206.0%
1.9%
AMLXAMYLYX PHARMACEUTICALS INC$50.6M1.88%$6.41$18.27+185.0%
1.9%
IMTXIMMATICS N.V$50.5M1.87%$5.38$9.95+84.9%
1.9%
AKROAKERO THERAPEUTICS INC$48.9M1.81%β€”β€”
1.8%
OMDAOMADA HEALTH INC$44.4M1.65%$18.30$22.39+22.4%
1.6%
FOLDAMICUS THERAPEUTICS INC$42.5M1.57%β€”β€”
1.6%
ROIVROIVANT SCIENCES LTD$37.5M1.39%$11.27$35.13+211.7%
1.4%
MRUSMERUS N V$37.3M1.38%β€”β€”
1.4%
SLNOSOLENO THERAPEUTICS INC$36.1M1.34%$83.78β€”
1.3%
ATXSASTRIA THERAPEUTICS INC$34.8M1.29%β€”β€”
1.3%
IMVTIMMUNOVANT INC$34.2M1.27%$16.00$38.79+142.4%
1.3%
NBIXNEUROCRINE BIOSCIENCES INC$32.1M1.19%$125.69$174.26+38.6%
1.2%
PRAXPRAXIS PRECISION MEDICINES I$31.7M1.17%$42.05$318.52+657.5%
1.2%
BSXBOSTON SCIENTIFIC CORP$30.1M1.11%$107.41$45.14-58.0%
1.1%
CAICARIS LIFE SCIENCES INC$29.3M1.09%$26.72$18.30-31.5%
1.1%
XBIPUTSPDR SERIES TRUST$24.9M0.92%$82.55$160.46+94.4%
0.9%
ISRGINTUITIVE SURGICAL INC$24.5M0.91%$543.41$426.01-21.6%
0.9%
ADMAADMA BIOLOGICS INC$23.7M0.88%$18.21$8.95-50.9%
0.9%
BBNXBETA BIONICS INC$23.2M0.86%$14.56$16.76+15.1%
0.9%

Quarter-on-Quarter Activity

Q2 2025 vs. Q1 2025

New Positions (8)

TickerIssuerNotionalSince Filing
ASNDASCENDIS PHARMA A/S$166.4M+59.0%
OMDAOMADA HEALTH INC$44.4M+22.4%
ROIVROIVANT SCIENCES LTD$37.5M+211.7%
CAICARIS LIFE SCIENCES INC$29.3M-31.5%
XBIPUTSPDR SERIES TRUST$24.9M+94.4%
CTMXCYTOMX THERAPEUTICS INC$15.9M
CRLCHARLES RIV LABS INTL INC$15.2M
TVTXTRAVERE THERAPEUTICS INC$12.3M

Exited Positions (8)

TickerIssuerNotional
ITCIINTRA-CELLULAR THERAPIES INC$103.7M
IOVAIOVANCE BIOTHERAPEUTICS INC$42.3M
ARGXARGENX SE$35.2M
PCVXVAXCYTE INC$26.7M
MDGLMADRIGAL PHARMACEUTICALS INC$15.4M
DXCMDEXCOM INC$12.2M
ACRVACRIVON THERAPEUTICS INC$10.9M
CRGXCARGO THERAPEUTICS INC$9.9M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
EWTXEDGEWISE THERAPEUTICS INC$49.8M+828.0%+201.8%
NRIXNURIX THERAPEUTICS INC$9.0M+268.7%
NBIXNEUROCRINE BIOSCIENCES INC$21.0M+154.9%+38.6%
BSXBOSTON SCIENTIFIC CORP$17.0M+115.4%-58.0%
RGENREPLIGEN CORP$4.1M+27.9%
INSMINSMED INC$26.6M+27.7%+10.9%
AKROAKERO THERAPEUTICS INC$16.8M+15.5%
ISRGINTUITIVE SURGICAL INC$4.4M+11.1%-21.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
KALAKALA BIO INC$-1.3M-80.1%
AVTXAVALO THERAPEUTICS INC$-3.5M-73.1%
SLNOSOLENO THERAPEUTICS INC$-71.6M-71.4%
JANXJANUX THERAPEUTICS INC$-19.4M-69.8%
FOLDAMICUS THERAPEUTICS INC$-132.7M-65.5%
CNTACENTESSA PHARMACEUTICALS PLC$-28.6M-62.3%
ALDXALDEYRA THERAPEUTICS INC$-37.8M-56.3%
CTNMCONTINEUM THERAPEUTICS INC$-7.3M-51.5%
← Back to Hedge Funds